<> Dr. Lal Pathlabs Share Price Today: Live Dr. Lal Pathlabs Share Price NSE/BSE | 5paisa
LALPATHLAB

Dr. Lal Pathlabs Share PriceDr. Lal Pathlabs

₹2101.3
43 (2.09%)
  • Advice
  • Hold
As on 01 February, 2023 | 05:34 BSE: 539524 NSE: LALPATHLAB

Dr. Lal Pathlabs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Dr. Lal Pathlabs

Start SIP

Dr. Lal Pathlabs Share Price

  • Over 1 Month -7.04%
  • Over 3 Month -18.02%
  • Over 6 Month -8.78%
  • Over 1 Year -29.26%

Dr. Lal Pathlabs Key Statistics

P/E Ratio 70.7
PEG Ratio -1.8
Market Cap Cr 17,515
Price to Book Ratio 11.4
EPS 41.3
Dividend 0.6
Relative Strength Index 38.73
Money Flow Index 16.79
MACD Signal -60.13
Average True Range 59.11

Dr. Lal Pathlabs Investment Rating

  • Master Rating:
  • Dr Lal Pathlabs has an operating revenue of Rs. 2,018.90 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 23% is great, ROE of 22% is exceptional. The company has a reasonable debt to equity of 11%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 16 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 146 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Dr. Lal Pathlabs Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 467439415
Operating Expenses Qtr Cr 337330310
Operating Profit Qtr Cr 130109105
Depreciation Qtr Cr 211922
Interest Qtr Cr 10811
Tax Qtr Cr 282220
Net Profit Qtr Cr 798065

Dr. Lal Pathlabs Technicals

EMA & SMA

Current Price
₹2101.3
43 (2.09%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 2155.25
  • 50 Day
  • 2254.34
  • 100 Day
  • 2324.97
  • 200 Day
  • 2434.13
  • 20 Day
  • 2160.09
  • 50 Day
  • 2290.61
  • 100 Day
  • 2381.19
  • 200 Day
  • 2328.21

Dr. Lal Pathlabs Resistance and Support

PIVOT
₹2054.1
Resistance
First Resistance 2074.2
Second Resistance 2090.1
Third Resistance 2110.2
RSI 38.73
MFI 16.79
MACD Single Line -60.13
MACD -61.78
Support
First Resistance 2038.2
Second Resistance 2018.1
Third Resistance 2002.2

Dr. Lal Pathlabs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 93,558 3,574,851 38.21
Week 111,815 3,895,635 34.84
1 Month 169,250 4,534,196 26.79
6 Month 278,543 7,955,179 28.56

Dr. Lal Pathlabs Result Highlights

Dr. Lal Pathlabs Synopsis

NSE-Medical-Services

Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1872.71 Cr. and Equity Capital is Rs. 83.35 Cr. for the Year ended 31/03/2022. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.
Market Cap 17,515
Sales 1,744
Shares in Float 3.75
No of funds 288
Yield 0.57
Book Value 11.86
U/D Vol ratio 1
LTDebt / Equity 11
Alpha -0.11
Beta 0.79

Dr. Lal Pathlabs

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 55.05%55.05%55.05%
Mutual Funds 2.71%2.76%2.83%
Insurance Companies 2.37%2.33%2.46%
Foreign Portfolio Investors 23.8%23.26%22.37%
Financial Institutions/ Banks
Individual Investors 9.02%8.23%10.44%
Others 7.05%8.37%6.85%

Dr. Lal Pathlabs Management

Name Designation
Brig.(Hony) Dr. Arvind Lal Executive Chairman
Dr. Om Prakash Manchanda Managing Director
Dr. Vandana Lal Executive Director
Mr. Rahul Sharma Non Executive Director
Mr. Anoop Mahendra Singh Independent Director
Mr. Sunil Varma Lead Independent Director
Mr. Harneet Singh Chandhoke Independent Director
Dr. Saurabh Srivastava Independent Director
Mrs. Somya Satsangi Independent Director
Dr. Archana Lal Erdmann Non Executive Director

Dr. Lal Pathlabs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Dr. Lal Pathlabs Corporate Action

Date Purpose Remarks
2023-02-02 Quarterly Results
2022-11-08 Quarterly Results
2022-07-28 Quarterly Results & Interim Dividend
2022-05-17 Audited Results & Final Dividend
2022-02-10 Quarterly Results
Date Purpose Remarks
2022-08-09 INTERIM Rs.6.00 per share(60%)Interim Dividend
2022-06-23 FINAL Rs.6.00 per share(60%)Final Dividend
2021-08-22 INTERIM Rs.6.00 per share(60%)Interim Dividend
2021-07-22 FINAL Rs.8.00 per share(80%)Final Dividend
2021-02-10 INTERIM Rs.6.00 per share (60%) Second Interim Dividend

Dr. Lal Pathlabs MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 24929
Kotak Equity Opportunities Fund Growth 11555
ICICI Prudential Equity Arbitrage Fund Regular Growth 10785
Axis Growth Opportunities Fund Regular Growth 8257
UTI Mid Cap Fund Regular Plan Growth 7230

Dr. Lal Pathlabs FAQs

What is Share Price of Dr. Lal Pathlabs ?

Dr. Lal Pathlabs share price is ₹2101 As on 01 February, 2023 | 05:20

What is the Market Cap of Dr. Lal Pathlabs ?

The Market Cap of Dr. Lal Pathlabs is ₹17515.2 Cr As on 01 February, 2023 | 05:20

What is the P/E ratio of Dr. Lal Pathlabs ?

The P/E ratio of Dr. Lal Pathlabs is 70.7 As on 01 February, 2023 | 05:20

What is the PB ratio of Dr. Lal Pathlabs ?

The PB ratio of Dr. Lal Pathlabs is 11.4 As on 01 February, 2023 | 05:20

Q2FY23